Susquehanna International Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Susquehanna International Group’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,175	Closed	-$47K	–	14359
2022 Q2	$47K	Sell	1,175 -50	-4%	-$1.94K	﹤0.01%	12016
2022 Q1	$64K	Sell	1,225 -970	-44%	-$48.8K	﹤0.01%	12192
2021 Q4	$122K	Buy	2,195 +840	+62%	+$53.6K	﹤0.01%	11995
2021 Q3	$105K	Buy	1,355 +490	+57%	+$41.5K	﹤0.01%	12044
2021 Q2	$112K	Sell	865 -755	-47%	-$104K	﹤0.01%	12036
2021 Q1	$267K	Buy	+1,620	New	+$312K	﹤0.01%	10846

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Susquehanna International Group's TCON Position: Q2 2024 in Review

Susquehanna International Group sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 3,893 shares — an estimated $33.5K sold.

Susquehanna International Group first reported a position in TCON in Q1 2015 and held it in 12 quarters. The position peaked at $173K in Q1 2015. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Susquehanna International Group reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 3,893 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $33.5K.
Susquehanna International Group first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
Susquehanna International Group's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $173K in Q1 2015.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.